Search hospitals > Texas > Houston
Memorial Hermann Hospital
Claim this profileHouston, Texas 77030
Global Leader in Cancer
Global Leader in Stroke
Conducts research for Heart Failure
Conducts research for Ischemic Stroke
Conducts research for Lung Cancer
242 reported clinical trials
37 medical researchers
Summary
Memorial Hermann Hospital is a medical facility located in Houston, Texas. This center is recognized for care of Cancer, Stroke, Heart Failure, Ischemic Stroke, Lung Cancer and other specialties. Memorial Hermann Hospital is involved with conducting 242 clinical trials across 376 conditions. There are 37 research doctors associated with this hospital, such as Sean Savitz, Jay-Jiguang Zhu, MD, Abhijeet Dhoble, MD, and Richard Smalling, MD.Area of expertise
1Cancer
Global LeaderStage III
Stage II
Stage I
2Stroke
Global LeaderTop PIs
Sean SavitzThe University of Texas Health Science Center at Houston2 years of reported clinical research
Studies Stroke
Studies Ischemic Stroke
12 reported clinical trials
16 drugs studied
Jay-Jiguang Zhu, MDMemorial Hermann Texas Medical Center7 years of reported clinical research
Studies Glioblastoma
Studies Gliosarcoma
8 reported clinical trials
32 drugs studied
Abhijeet Dhoble, MDThe University of Texas Health Science Center at Houston2 years of reported clinical research
Studies Stroke
Studies Tricuspid Regurgitation
7 reported clinical trials
14 drugs studied
Richard Smalling, MDThe University of Texas Health Science Center at Houston6 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Tricuspid Regurgitation
6 reported clinical trials
8 drugs studied
Clinical Trials running at Memorial Hermann Hospital
Non-Small Cell Lung Cancer
Lung Cancer
Stroke
Heart Failure
Bleeding
Gallstones
Aortic Valve Stenosis
Pulmonary Arterial Hypertension
Pulmonary Hypertension
Mitral Valve Regurgitation
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Memorial Hermann Hospital?
Memorial Hermann Hospital is a medical facility located in Houston, Texas. This center is recognized for care of Cancer, Stroke, Heart Failure, Ischemic Stroke, Lung Cancer and other specialties. Memorial Hermann Hospital is involved with conducting 242 clinical trials across 376 conditions. There are 37 research doctors associated with this hospital, such as Sean Savitz, Jay-Jiguang Zhu, MD, Abhijeet Dhoble, MD, and Richard Smalling, MD.